Physician profile
David Liang
NPI 1063779411
$991.03
in general payments reported to CMS, 2019-2025
18 companies · $281 in 2025
The $281 reported for 2025 was more than what 83% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $13.18 · 2023: $163 · 2024: $207 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $651.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $167.42 | 2019-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $116.45 | 2023-2025 | |
| Corium, LLC | $110.74 | 2023-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $109.02 | 2019-2024 | Vaxelis, Gardasil 9, Vaqta |
| Pfizer INC. | $101.73 | 2019-2024 | |
| Ironshore Pharmaceuticals INC. | $99.52 | 2019 | |
| Sanofi Pasteur INC. | $51.95 | 2019-2023 | |
| Tris Pharma INC | $44.71 | 2019-2025 | Onyda Xr |
| Alk-Abello, INC | $34.22 | 2025 | Neffy |
| Rhodes Pharmaceuticals L.P. | $23.31 | 2019 | |
| Shire North American Group INC | $21.18 | 2019 | |
| Biomarin Pharmaceutical INC. | $17.97 | 2025 | Voxzogo 1.2mg |
| Genentech USA, INC. | $16.84 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.37 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $15.71 | 2025 | Neffy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $15.18 | 2019 | |
| Lnhc, INC | $14.81 | 2025 | Zelsuvmi |
| Supernus Pharmaceuticals, INC. | $13.90 | 2025 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Liang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.